University College London (UCL)
328 articles about University College London (UCL)
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Theragnostics reports positive clinical trial results from prostate cancer study
10/2/2019
Study evaluates clinical utility of 68Ga THP-PSMA PET/CT imaging in men with newly diagnosed and recurrent prostate cancer
-
cTAP Publishes Comprehensive Analysis of the North Star Ambulatory Assessment (NSAA), a Newly Adopted Primary Outcome Measure in Clinical Trials of Patients with Duchenne Muscular Dystrophy
9/26/2019
The collaborative Trajectory Analysis Project, a multi-stakeholder, global coalition in Duchenne muscular dystrophy, publishes research in the journal PLOS ONE providing quantitative insights to assist the design and analysis of clinical trials in patients with DMD.
-
AstronauTx secures £6.5 million investment for new approach to dementia therapeutics
8/12/2019
A new UK-based biotech company, AstronauTx Ltd, which builds on the work from the Alzheimer’s Research UK UCL Drug Discovery Institute (DDI), has received an investment of £6.5 million from the Dementia Discovery Fund (DDF).
-
According to a University College London (UCL) report, British researchers are being shut out of major European research partnerships because of concerns over a no-deal Brexit.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Royal Manchester Children’s Hospital MPSIIIA patient receives world’s first gene therapy treatment for life-limiting genetic condition
5/24/2019
A two-year old patient at the Royal Manchester Children’s Hospital (RMCH) is the first in the world to receive a pioneering new ex vivogene therapy treatment using lentiviral vector-modified autologous stem cells for the rare and life-limiting genetic condition, Mucopolysaccharidosis IIIA (MPSIIIA).
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Corrected: Immunovia and University College of London Sign Agreement to Expand Validation Studies of IMMray™ PanCan-d for Early Signs and Symptoms
4/10/2019
Immunovia announced that Prof. Stephen Pereira and his team at the institute for Liver and Digestive Health, University College London (UCL) will expand the prospective collection of blood samples funded by Immunovia and that started with the PanSYM-1 pilot study.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Although cautious about using the word “cure,” researchers have described a second person globally to be cleared of HIV, the virus that causes AIDS. The new patient, who remains unnamed, is dubbed the “London Patient.”
-
Bristol-Myers Squibb is teaming up with Cancer Research UK and the Francis Crick Institute to create guidelines for immuno-oncology therapy development. This “rule book,” will focus on lung cancer treatments.
-
University College London in Strategic Alliance with Pall Biotech to Open Fit-for-Purpose Biotech Centre of Excellence for Research, Development and Training
10/3/2018
Pall Corporatio has progressed a strategic partnership with the University College London (UCL) Biochemical Engineering department with the creation of the UCL-Pall Biotech Centre of Excellence (CoE) for research and training.
-
Swiss-based Roche announced it is buying UK-based Tusk Therapeutics in a deal that could hit $758 million (U.S.).
-
Zeiss Highlights the Xradia 810 Ultra X-Ray Microscope
9/19/2018
Advancing the next generation of batteries
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Synpromics Announces New Partnership with UCL to Develop Novel Gene Therapies for Blood-Based Disorders
1/25/2018
This new partnership further expands Synpromics’ activities in the cell and gene therapy sector, as it builds on its strategy of establishing partnerships with leading academics in the UK to integrate its technology into the next generation of gene-based medicines.
-
TC BioPharm Announces Car-T Licensing Deal With University College London Business
9/6/2017
-
Saphetor SA Signs Multiple Service Agreements With University College London To Analyze Exome And Whole-Genome Sequencing Data
5/25/2017
-
MRI Scans Can Help Spot HIV In The Brain, University College London Reveals
3/13/2017